HEALTH● LOWSep 1 · Sep 1, 2026, 4:45 AM
Eli Lilly diabetes drug Mounjaro approved to reduce cardiovascular risks
businesstoday.in · India · global
The diabetes drug Mounjaro, developed by Eli Lilly, has been approved for its ability to reduce cardiovascular risks. This represents a significant advancement in treating diabetes and related heart conditions.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More from India
POLITICS7m agoClean energy investments helped India soften West Asia crisis impact: PM ModiThe HinduPOLITICS8m agoRevanth Reddy calls for world-class, permanent facilities for Khelo India GamesThe HinduMILITARY7h agoIndia offers Asean counterterrorism lessons, but will one size fit all?South China Morning PostDISASTERBREAKING8h agoThousands evacuated as India braces for second cyclone in a weekAl Jazeera [en]
More in Health
HEALTHBREAKING20m agoEbola kills over 5,300 in fastest-growing outbreak on recordEuroNews [en]HEALTH58m agoUS Approves Cheap Version Of HIV Prevention ShotChannels TVHEALTH1h agoUS approves cheap generic version of breakthrough HIV prevention jab – in major step towards ending AidsThe Independent WorldHEALTH1h agoUS approves economic version of HIV preventive treatmentClarín